Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward ...

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need ...

Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...

Icotyde (icotrokinra) has been approved by the US FDA to treat moderate-to-severe plaque psoriasis (PsO) in both adults and ...

Envision Pharma Group (Envision) has appointed Darren Coleman as Executive Vice President, Chief Information Officer. Coleman ...

AL-S Pharma has released new data from the phase 2 trial evaluating its drug AP-101 in patients with amyotrophic lateral ...

Richmond Pharmacology has appointed John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in ...

Grifols have announced proof-of-concept data from its Chronos-PD programme, which uses AI, advanced proteomics and real-world ...

Envision Pharma Group (Envision) has appointed Jay Ferro as President, Technology and Chief Product Officer (CPO). He joins ...